Mira Pharmaceuticals (MIRA) Accumulated Expenses (2022 - 2025)

Mira Pharmaceuticals (MIRA) posted Accumulated Expenses of $572865.0 for Q4 2025, up 10315.73% sequentially from $5500.0 in Q1 2025, and up 90.96% YoY from $300000.0 in Q4 2024.

Mira Pharmaceuticals (MIRA) Accumulated Expenses (2022 - 2025) Analysis & Trends

Mira Pharmaceuticals (MIRA) has 4 years of Accumulated Expenses data on file, last reported at $572865.0 in Q4 2025.

  • Quarterly Accumulated Expenses rose 90.96% year-over-year to $572865.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $572865.0 (up 90.96% YoY) and the FY2025 annual result came in at $572865.0, up 90.96% from the prior year.
  • Accumulated Expenses improved to $572865.0 in Q4 2025 per MIRA's latest filing, from $5500.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $572865.0 in Q4 2025, with the low at $5500.0 in Q1 2025.
  • Average Accumulated Expenses over 4 years is $136042.3, with a median of $14472.0 recorded in 2023.
  • Year-over-year, Accumulated Expenses jumped 1972.97% in 2024 and sank 62.0% in 2025.
  • Mira Pharmaceuticals' Accumulated Expenses stood at $34987.0 in 2022, then slumped by 58.64% to $14472.0 in 2023, then jumped by 1972.97% to $300000.0 in 2024, then soared by 90.96% to $572865.0 in 2025.
  • Business Quant data shows MIRA's Accumulated Expenses at $572865.0 in Q4 2025, $5500.0 in Q1 2025, and $300000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Mira Pharmaceuticals 22.51 Mn 11.48 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 572,865.00
Mar 31, 2025 5,500.00
Dec 31, 2024 300,000.00
Sep 30, 2024 10,000.00
Mar 31, 2024 14,472.00
Dec 31, 2023 14,472.00
Dec 31, 2022 34,987.00